Search Results
FDA approves promising treatment for multiple myeloma patients
FDA Approval of a Biosimilar, Promising Data in Myeloma and GBM, and More
FDA Approval in Myeloma, Breakthrough Designations in RCC and Aplastic Anemia, and More
Dr. Martin on FDA Approval of Denosumab in Multiple Myeloma
Current and Future Directions for Novel Therapy for Multiple Myeloma: Paul G. Richardson, MD
Promising cellular therapies emerging in multiple myeloma
FDA approval of teclistamab for R/R multiple myeloma and the value of immunotherapies
FDA Approval in Myeloma, Priority Review in ALL, and 2017 GU Cancers Symposium Highlights
Promising novel treatments in multiple myeloma
FDA expected to approve new multiple myeloma treatment
FDA Approval of Frontline Daratumumab Plus VMP in Multiple Myeloma
Is CAR T-cell therapy being used to treat newly diagnosed multiple myeloma?
